Bio Impact Capital LLC Mirum Pharmaceuticals, Inc. Transaction History
Bio Impact Capital LLC
- $641 Million
- Q3 2024
A detailed history of Bio Impact Capital LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 492,723 shares of MIRM stock, worth $21.9 Million. This represents 3.0% of its overall portfolio holdings.
Number of Shares
492,723
Previous 492,569
0.03%
Holding current value
$21.9 Million
Previous $16.8 Million
14.11%
% of portfolio
3.0%
Previous 2.7%
Shares
6 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$292 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$199 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$153 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$144 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$137 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...